Literature DB >> 17627545

Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase family.

A Angelucci1, M Bologna.   

Abstract

The formation of capillary-like structures during angiogenesis requires a series of well-orchestrated cellular events allowing endothelial cells and pericytes to migrate into the perivascular space. The proper activation of the migratory machinery in these cells is fine controlled by the presence of angiogenic challenges and by the interactions with extracellular matrix. The two members of the focal adhesion protein tyrosine kinases (FA-PTKs), FAK and PYK2, play a central role in modulating endothelial and vascular smooth muscle cells migration confirming the well consolidated observations in other migrating cell types. However accumulating data reveal that FAK and PYK2 are involved in several cell processes including cell proliferation and survival. FAK, once localized to focal adhesions, is thought to be one of the principal effectors in linking signals initiated by integrins and growth factor receptors to cytoskeleton, thus controlling migration. Although more obscure, and differently regulated, the function of PYK2 seems to be similar to that of FAK, but restricted to few cell types, including vasculature forming cells. FAK and PYK2 exert a primary role as adaptor proteins able to recruit, with high turnover, several proteins which in turn, through their docking domains and tyrosine kinase activity, determine both the turnover in focal adhesion assembly and the specificity of downstream signaling. The characterization of functional interactions of FA-PTKs may provide new potential therapeutic targets in order to control vascular pathological processes including angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627545     DOI: 10.2174/138161207781039643

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

1.  Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.

Authors:  Rebecca L Stone; Keith A Baggerly; Guillermo N Armaiz-Pena; Yu Kang; Angela M Sanguino; Duangmani Thanapprapasr; Heather J Dalton; Justin Bottsford-Miller; Behrouz Zand; Rehan Akbani; Lixia Diao; Alpa M Nick; Koen DeGeest; Gabriel Lopez-Berestein; Robert L Coleman; Susan Lutgendorf; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2014-04-23       Impact factor: 4.742

2.  Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.

Authors:  Paola Chiodelli; Chiara Urbinati; Stefania Mitola; Elena Tanghetti; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

Review 3.  Targeting cytoskeleton reorganisation as antimetastatic treatment.

Authors:  Miguel Quintela-Fandino; Antonio González-Martín; Ramon Colomer
Journal:  Clin Transl Oncol       Date:  2010-10       Impact factor: 3.405

Review 4.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

5.  Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles.

Authors:  Andrea Caporali; Elisabetta Pani; Anton J G Horrevoets; Nicolle Kraenkel; Atsuhiko Oikawa; Graciela B Sala-Newby; Marco Meloni; Brunella Cristofaro; Gallia Graiani; Aurelie S Leroyer; Chantal M Boulanger; Gaia Spinetti; Sung Ok Yoon; Paolo Madeddu; Costanza Emanueli
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

6.  The dual kinase complex FAK-Src as a promising therapeutic target in cancer.

Authors:  Victoria Bolós; Joan Manuel Gasent; Sara López-Tarruella; Enrique Grande
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

7.  TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis.

Authors:  Alexander Schultze; Sebastian Decker; Jasmin Otten; Andrea Kristina Horst; Gabi Vohwinkel; Gunter Schuch; Carsten Bokemeyer; Sonja Loges; Walter Fiedler
Journal:  Invest New Drugs       Date:  2009-09-26       Impact factor: 3.850

Review 8.  Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle.

Authors:  Dale D Tang; Yana Anfinogenova
Journal:  J Cardiovasc Pharmacol Ther       Date:  2008-01-22       Impact factor: 2.457

Review 9.  p130 Crk-associated substrate (CAS) in vascular smooth muscle.

Authors:  Dale D Tang
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-03-27       Impact factor: 2.457

10.  c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases.

Authors:  Monica Guma; Gary S Firestein
Journal:  Open Rheumatol J       Date:  2012-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.